Monday, September 30, 2019

CBD producer sues Oregon hemp seed company for $44 million over ruined crop

A Kentucky-based CBD company filed a $44 million lawsuit against an Oregon hemp seed company, claiming the hempseeds it supplied were bogus and contributed to ruining the company’s 2019 crop. Lexington-based Elemental Processing estimated it lost at least $44 million in profits after HP Farms of Troutdale, Oregon, allegedly supplied it with more than 6 […]

CBD producer sues Oregon hemp seed company for $44 million over ruined crop is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/30/cbd-producer-sues-oregon-hemp-seed-company-for-44-million-over-ruined-crop/?utm_source=rss&utm_medium=rss&utm_campaign=cbd-producer-sues-oregon-hemp-seed-company-for-44-million-over-ruined-crop

Water Rights Are Still a Major Concern for California Cannabis Operators

california cannabis water rights

Last week, the California Water Boards requested on Twitter to commercial cannabis cultivators in Mendocino, Trinity, and Humboldt Counties (the “Emerald Triangle”) that, “if you are among the 270 folks who receive a certified letter stating you lack appropriate permits, please respond to our Cannabis Compliance Response Portal.” Water rights have been an ongoing issue for California cannabis operators, particularly in the Emerald Triangle here in Northern California where environmental concerns stemming from water usage abound, particularly by black and grey market operators.

The letters were sent to landowners whose properties “appear … to be used for cannabis cultivation or associated activities,” but for which “there is no record of any person associated with [the] property having enrolled in the State Water Board’s Cannabis Cultivation Program.” The letters further warn recipients that they must obtain proper permission for the water rights utilized for cannabis cultivation and if they fail to do so, threaten fines or loss of state cannabis cultivation permits.

The California Water Boards Cannabis Cultivation Program was approved and put into the state’s regulatory code by the Office of Administrative Law on December 18, 2017 and is intended to “address potential water quality and quantity issues related to cannabis cultivation.” Specifically, for the uninitiated, the Water Boards established a Cannabis Policy that states as follows:

“The Cannabis Policy establishes principles and guidelines (requirements) for cannabis cultivation activities to protect water quality and instream flows. The purpose of the Cannabis Policy is to ensure that the diversion of water and discharge of waste associated with cannabis cultivation does not have a negative impact on water quality, aquatic habitat, riparian habitat, wetlands, and springs. The Cannabis Policy requirements are primarily implemented through the Water Boards Cannabis Cultivation General Order and Cannabis SIUR permits in addition to the California Department of Food and Agriculture’s CalCannabis Cultivation Licensing Program.”

The Water Boards seeks to ensure that discharges to California waters do not adversely affect the quality and uses of our waters via the Cannabis Cultivation General Order’s Waste Discharge Requirement (WDR). The WDR regulates discharges of waste associated with marijuana cultivation in the state, and addresses threats of waste discharge stemming from “irrigation, runoff, over fertilization, pond failure, road construction, grading activities, domestic and cultivation related waste, etc.” All commercial cannabis cultivators must obtain coverage under the Cannabis Cultivation General Order. More information for cultivators can be found on the Boards’ Cannabis Water Quality page.

In addition, the Small Irrigation Use Registration (SIUR) for Cannabis Cultivation requires cannabis cultivators to forbear (or cease) from diverting surface water during the dry season. “The State Water Board has developed the Cannabis SIUR Program as an expedited process for cannabis cultivators to develop and install storage.  The Cannabis SIUR allows for the diversion and storage of up to 20 acre-feet per year and incorporates the requirements of the Cannabis Policy, amongst other requirements, as general conditions.”

Cultivators need to be aware of, and comply with, all regulations pertaining to water rights and usage in California. Relevant information on the Water Boards’ Cannabis Enforcement Unit can be found here.



source https://hempgenixs.com/2019/09/30/water-rights-are-still-a-major-concern-for-california-cannabis-operators/?utm_source=rss&utm_medium=rss&utm_campaign=water-rights-are-still-a-major-concern-for-california-cannabis-operators

Hemp in California: Counties, cities remain divided on production

(Editor’s note: This is part of an occasional series on California’s hemp industry.) California’s county-by-county regulatory landscape for hemp production is as varied as its actual scenery. In some of its counties, California is one of the last strongholds against hemp production, while in others, efforts to grow the crop are underway or ordinances have […]

Hemp in California: Counties, cities remain divided on production is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/30/hemp-in-california-counties-cities-remain-divided-on-production/?utm_source=rss&utm_medium=rss&utm_campaign=hemp-in-california-counties-cities-remain-divided-on-production

Sunday, September 29, 2019

Hemp-CBD Across State Lines: Kansas

kansas hemp cbd

The Agriculture Improvement Act of 2018 (“2018 Farm Bill”) legalized hemp by removing the crop and its derivatives from the definition of marijuana under the Controlled Substances Act (“CSA”) and by providing a detailed framework for the cultivation of hemp. The 2018 Farm Bill gives the US Department of Agriculture (“USDA”) regulatory authority over hemp cultivation at the federal level. In turn, states have the option to maintain primary regulatory authority over the crop cultivated within their borders by submitting a plan to the USDA.

This federal and state interplay has resulted in many legislative and regulatory changes at the state level. Indeed, most states have introduced (and adopted) bills that would authorize the commercial production of hemp within their borders. A smaller but growing number of states also regulate the sale of products derived from hemp.

In light of these legislative changes, we are presenting a 50-state series analyzing how each jurisdiction treats hemp-derived cannabidiol (“Hemp CBD”). Each Sunday, we summarize a new state in alphabetical order. Today, we turn to Kansas.

In 2018, Kansas legislators enacted the Alternative Crop Research Act (“Act”), which authorizes the cultivation of industrial hemp for research purposes only and is overseen by the Kansas Department of Agriculture (“KDA”). To implement the Act, the KDA issued regulations that went into effect on February 8, 2019.

In May 2019, Governor Jeff Colyer signed into law Senate Substitute for House Bill (“HB”) 2167, which authorizes the commercial sale of hemp and hemp products containing less than 0.3% THC, pursuant to the 2018 Farm Bill, and ensures that hemp and hemp products are no longer treated as controlled substances.

Consequently, the Act was officially renamed the “Commercial Industrial Hemp Act” but will remain in effect until the KDA establishes the commercial production of industrial hemp in the state or a federal plan by the USDA allowing for the cultivation and production of commercial industrial hemp is adopted, whichever occurs first.

With this in mind, the following sections address the current rules under the Act and the future regulations under HB 2167.

State License or Permit Status

  • Act: Currently, the KDA requires each individual who is growing, processing, selling and distributing hemp to obtain a license. Note that the rules do not provide whether a license is required to manufacture, sell and distribute Hemp-CBD products. However, in May 2018, Governor Jeff Colyer signed legislation amending the state’s criminal code to exclude CBD from the state’s definition of marijuana, which means that the sale of Hemp-CBD products is authorized if the oil contains no THC.
  • HB 2167: Although HB 2167 gives the KDA the authority to monitor and regulate the commercial production of hemp within the state, the new law does not provide whether a license will be required to sell and distribute Hemp-CBD products. The new law is also unclear about whether certain categories of Hemp-CBD products that may be lawfully manufactured, marketed, distributed, or sold in the state. HB 2167 expressly bans Hemp-CBD smokable products as well as teas, liquids, solids, and other hemp products intended for human consumption containing any ingredient derived from hemp and prohibited by the Kansas Food, Drug, and Cosmetic Act. However, the new law also states that it does not explicitly prohibit the use of Hemp-CBD ingredients, such as CBD oil, in such hemp products.

Possession
Kansas does not have Hemp-CBD laws or medical marijuana laws. However, as previously stated, Kansas law removed CBD products free of THC from the state’s definition of marijuana. Unlike CBD-exemption laws enacted in other states, Kansas law permits all adults, not just those with qualified medical conditions, to possess and purchase CBD products containing no THC.

Transportation

  • Act: The KDA requires individuals who transport hemp to obtain a research distributor license. However, the rules do not provide whether a license is required to transport Hemp-CBD products that contain THC.
  • HB 2167: Neither HB 2167 nor the proposed rules from KDA address this issue.

Marketing/Advertising Regulations

  • Act: The Act does not impose restrictions on marketing or advertising of hemp or hemp products under the research program.
  • HB 2167: The new law bans the marketing of all Hemp-CBD products prohibited in the statute and listed above.

In enacting HB 2167, Kansas showed a desire to provide the Kansas hemp community with an opportunity to fulfill its economic potential. However, to reach this objective, the state will need to clarify its policies regarding the manufacture, distribution, marketing and sale of Hemp-CBD products.

Stay tuned to the Canna Law Blog for developments on hemp and Hemp CBD in Kansas and other states across the country. For previous coverage in this series, check out the links below:



source https://hempgenixs.com/2019/09/29/hemp-cbd-across-state-lines-kansas/?utm_source=rss&utm_medium=rss&utm_campaign=hemp-cbd-across-state-lines-kansas

Saturday, September 28, 2019

Seizures at School: Arizona Federal Court Says IDEA Protections Do Not Extend to Medical Cannabis Use

idea arizona cannabis school

We’ve written a lot about cannabis and the Controlled Substances Act.  From immigration to waste dumping. From the Fair Labor Standards Act to the STATES Act, our articles run the gamut. Not long ago we wrote about a decision by the Second Circuit that may force the DEA to re- or deschedule marijuana after writing about the lawsuit when it was first filed last year. This lawsuit, you may recall, was brought by a group of five plaintiffs comprised of a child who uses cannabis oil successfully to treat life-threatening seizures, another child who treats with cannabis for Leigh Syndrome, a terminal neurological disorder, a former NFL linebacker, an Iraq War veteran, and a nonprofit. As sympathetic a group of plaintiffs as there ever were – and in my eyes equaled by the parents and child in the discussion that follows.

A recent federal court decision addresses the relationship between the Controlled Substances Act, the Individuals With Disabilities Education Act (“IDEA”), and state laws permitting the medical use of cannabis.  The ruling is Albuquerque Public Schools v. Sledge, Civ. No. 18-1029 KK/LF, Civ. No. 18-1041 KK/LF (D. Ariz. Aug. 8, 2019). (Email me if you’d like a copy of the ruling.) Briefly, IDEA makes available a “free and appropriate public education” (or FAPE) to eligible children with disabilities. IDEA requires that schools provide special education services as outlined in a student’s Individualized Education Program (“IEP”). The decision addresses several issues arising under the IDEA, but since this is a cannabis blog and since we are not education lawyers, this post focuses on the cannabis related issues.

Parents seek to have their daughter treated with cannabis oil for seizures that occur at school

P.S.G. (“Student”) was born in 2013. She has Dravet Syndrome and as a result has had life-threatening seizures since infancy. Her doctors have prescribed legal medications that have not always worked and have caused serious side effects including inconsolable screaming and respiratory depression. Student visited the emergency room frequently when these were the only medical treatments she took. In 2016, the New Mexico Department of Health (“NMDOH”) gave Student’s mother (“Mother”) authorization to treat her daughter with cannabis pursuant to New Mexico’s Lynn and Erin Compassionate Use Act (“CUA”), whose purpose is to allow the use of medical cannabis in some circumstances.

Parents found the administration of CBD three times daily and cannabis oil at the onset of a seizure greatly reduced the frequency and duration of Student’s seizures without any serious side effects.

In 2016, the Albuquerque Public Schools (“APS”) informed Mother that Student could not receive cannabis oil on school grounds. Mother then requested permission from APS for “homebound services.” The APS held a meeting to develop an IEP which proposed Student attend a special education preschool for one hour a day. Student began attending preschool accompanied by Mother, who sat in the classroom every day so she could remove Student from school to administer cannabis oil in the event of a seizure. This continued until Student reached kindergarten age.

In 2018, the APS held another meeting to develop Student’s IEP for the 2018-19 school year – her kindergarten year. Mother wanted Student to receive a public education and did not want to homeschool Student. APS proposed that Student attend full-day kindergarten at a neighborhood school with an one-on-one educational assistant. Mother proposed an abbreviated schedule because she was unable to accompany her daughter to school all day every day and was unwilling to send her daughter to school without the means for her to receive cannabis oil as a rescue medication.  APS rejected Mother’s proposal.

Parents then submitted a request for an IDEA hearing. Parents proposed that their daughter attend kindergarten full-time and receive cannabis as needed from trained school personnel. After receiving evidence over the course of three days, the hearing officer ruled that “[g]iven the child’s need for medication that the school cannot legally administer,” Student’s least restrictive environment was “the homebound setting with socialization opportunities.” The hearing officer described this educational plan as “a hybrid, homebound kindergarten placement” where Mother may attend school at her option with the school nurse administering Epidiolex.

The hearing officer also found that APS failed to provide Student with the services required by IDEA. APS appealed the ruling to the federal district court and argued the hearing officer erred exercising jurisdiction over issues related to medical cannabis and in concluding that Parents met their burden of proving that Student needs cannabis to treat her seizure disorder. APS also alleged that “the IDEA does not require a school district to accommodate the use of an illegal substance to provide a FAPE.”

The federal court rules that the IDEA does not require the Arizona Public Schools to administer or accommodate the administration of cannabis to satisfy its obligation to provide students with a free and public education

The court began its analysis by explaining that with one exception, the possession, use, and distribution of cannabis for any reason is criminalized under federal law. The court further noted there are no federal exemptions for medical use. This meant that applying federal preemption principles, the CUA must give way to federal law. (Where state and federal law conflict, federal law wins.)

The court then addressed Parents’ claim that their daughter may receive cannabis “legally” under the CUA.  First, said the Court, the CUA does not make the possession, distribution or use of cannabis lawful but merely extends qualified immunity to qualified patients and their caregivers from state prosecution. This is different from making cannabis “legal,” and reading the CUA to do so would conflict with federal law (and federal law prevails).  The court also noted that the CUA did not extend its waiver to school staff who administer cannabis.

Next the court ruled that the IDEA cannot be interpreted to require APS to “accommodate” a federal crime to satisfy its obligations to provide student with a FAPE.  In so ruling, the court relied on cases holding that the Americans with Disabilities Act does not require the accommodation of medical cannabis use. The court then reasoned that cannabis could not be reasonably deemed a “related service” under the IDEA.

This ruling leaves the parents of a five-year old girl with undesirable options: send her to kindergarten and hope she doesn’t have a seizure since they cannot send her to school with what they know prevents seizures (cannabis oil), or homeschool her and provide her “socialization opportunities.”

In this author’s view, this decision is a sound reading of federal law and establishes the need for reforming marijuana laws at the federal level. The media is abuzz with articles about the so-called “vaping crisis,” but all too often ignore important stories like this in the ongoing conversation about marijuana reform.



source https://hempgenixs.com/2019/09/28/seizures-at-school-arizona-federal-court-says-idea-protections-do-not-extend-to-medical-cannabis-use/?utm_source=rss&utm_medium=rss&utm_campaign=seizures-at-school-arizona-federal-court-says-idea-protections-do-not-extend-to-medical-cannabis-use

Friday, September 27, 2019

What Should We Do About Vaping?

A single vape cartridge with end cap and tip cap sits on a bright yellow background.

There was a time when glossy magazine ads touted the supposed health benefits of cigarette smoking. For years, mainstream media and public officials routinely aided and abetted the false claims of the tobacco industry until the publication of the U.S. Surgeon General’s 1964 report on Smoking and Health. Cigarette commercials were subsequently banned from television, but tobacco products were never outlawed.



source https://hempgenixs.com/2019/09/27/what-should-we-do-about-vaping/?utm_source=rss&utm_medium=rss&utm_campaign=what-should-we-do-about-vaping

Early snow threatens Western hemp, sending farmers scrambling

Hemp farmers in the Western states are frantically harvesting their crops as news of an early-season storm threatens cold temperatures and severe wind chill, potentially dumping as much as 50 inches of snow on their fields. Jamie Fitterer, the owner of Montana Hemp Co., said farmers in Bozeman and around the state are “freaking out,” […]

Early snow threatens Western hemp, sending farmers scrambling is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/27/early-snow-threatens-western-hemp-sending-farmers-scrambling/?utm_source=rss&utm_medium=rss&utm_campaign=early-snow-threatens-western-hemp-sending-farmers-scrambling

The USPTO Has Granted its First Hemp Plant Patent

hemp patent

A first(!): Charlotte’s Web Holdings, Inc. (“CWB Holdings”), operated by the famed Stanley brothers, has secured the first-ever patent for a hemp cultivar in the United States. CWB Holdings is now the proud owner of a plant patent for “a new and distinct hemp cultivar designated as ‘CW2A.’” Patent documents describe CW2A as a hardy plant, resistant to cold, and capable of producing up to 6.24% CBD and only 0.27% THC (which is below the 0.3% threshold that separates hemp (legal) from marijuana (illegal) under the current federal scheme created by the Controlled Substances Act). The patent was granted on July 2, 2019 to the patent’s listed inventor, Co-Founder and Chairman of CWB Holdings, Joel Stanley.

It appears that CWB Holdings filed for the CW2A patent in May 2018, about half a year before the 2018 Farm Bill was signed into law by President Trump this past December. Because the patent is for a hemp cultivar within the threshold, CW2A will be legal to grow under the 2018 Farm Bill.

A plant patent is an intellectual property right that protects the key characteristics of a new and unique plant from being copied, sold, or used by others. A plant patent, as opposed to the broader utility patent, is only good for legal protection against a competitor growing the same cultivar from a clone. Despite its pretty narrow teeth, this is still groundbreaking news as it’s the very first plant patent for a cultivar of hemp issued in the United States. And, if the patent’s description of CW2A is correct, the plant would be ideal to curb the challenge that hemp farmers face of ensuring that the hemp crop doesn’t rise above that 0.3% THC threshold (or as industry-insiders say, “get hot”). To explain: typically, plants originally bred for other hemp products (seed, oil, fiber) is usually what is sourced for CBD products. These plants already yield about 0.3% THC, but you have to use a lot of plants, and cannabis is also great at sucking toxins from the soil. Therefore, a hemp cultivar like CW2A that is supposed to produce twice as much CBD by dry weight is a lot more beneficial to use. That’s why industry insiders seem to agree that CWB Holdings’ newest patent could be the start of its capturing a commanding share of the growing CBD market.

CEO of SIVA Enterprises and member of the California Bureau of Cannabis Control’s Cannabis Advisory Committee, Avis Bulbulyan, stated, “A lot of brands out there have catchy logos and catchy names, but the product inside is generic. There’s nothing proprietary about it.” In contrast, what CWB Holdings has secured is “huge” and “something tangible.”

It’s also entirely possible that we will learn of other patent filings soon. Utility patents, which cover seeds as well as complex chemical compositions, do not become publicly available under about eighteen months after their filing date. If CWB Holdings had filed for a utility patent around the same timeframe, that information won’t be public for a little while longer. We’ll be sure to check in and report back if it CWB Holdings is able to secure another win for its intellectual property portfolio.



source https://hempgenixs.com/2019/09/27/the-uspto-has-granted-its-first-hemp-plant-patent/?utm_source=rss&utm_medium=rss&utm_campaign=the-uspto-has-granted-its-first-hemp-plant-patent

Thursday, September 26, 2019

DEA added to list of agencies ordered to adapt to hemp legalization

The U.S. Drug Enforcement Administration is the latest agency being ordered to accommodate hemp legalization using a budget maneuver. Senate Majority Leader Mitch McConnell, R-Kentucky, announced Thursday he is championing a requirement that the DEA “identify or develop on-the-spot field testing technologies” to distinguish hemp from marijuana. The need for speedier cannabis tests has bedeviled […]

DEA added to list of agencies ordered to adapt to hemp legalization is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/26/dea-added-to-list-of-agencies-ordered-to-adapt-to-hemp-legalization/?utm_source=rss&utm_medium=rss&utm_campaign=dea-added-to-list-of-agencies-ordered-to-adapt-to-hemp-legalization

The outlook for Uruguayan hemp: Q&A with Sergio Vazquez of Uruguay’s agriculture ministry

(Editor’s note: Sergio Vazquez will appear at the MJBizDaily Latin American Cannabis Symposium, Sept. 30-Oct. 1, in Bogota, Colombia.) While Latin American countries generally have yet to see the formation of anything close to a real hemp market, some areas will begin to see an export stream next year. Even in Uruguay, the first country in […]

The outlook for Uruguayan hemp: Q&A with Sergio Vazquez of Uruguay’s agriculture ministry is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/26/the-outlook-for-uruguayan-hemp-qa-with-sergio-vazquez-of-uruguays-agriculture-ministry/?utm_source=rss&utm_medium=rss&utm_campaign=the-outlook-for-uruguayan-hemp-qa-with-sergio-vazquez-of-uruguays-agriculture-ministry

Report: CBD tops turmeric as top-selling dietary supplement, charting up 333% in natural channels

CBD rocketed to the best-selling herbal dietary supplement in natural sales channels last year, ousting turmeric as the No. 1 seller, according to a new report from the American Botanical Council. Sales of CBD products jumped 333% in 2018 in natural- and health-foods sales channels, notching $52.7 million in U.S. sales, the Texas-based industry group […]

Report: CBD tops turmeric as top-selling dietary supplement, charting up 333% in natural channels is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/26/report-cbd-tops-turmeric-as-top-selling-dietary-supplement-charting-up-333-in-natural-channels/?utm_source=rss&utm_medium=rss&utm_campaign=report-cbd-tops-turmeric-as-top-selling-dietary-supplement-charting-up-333-in-natural-channels

FDA to Clear a Path Within Four Months To Lawfully Market Hemp-Derived CBD Products

fda cbd hempBack in March, former Food and Drug Administration (“FDA”) Commission, Scott Gottlieb, explained it would take several years for the agency to come up with rules that would legalize the use of hemp-derived cannabidiol (Hemp-CBD) in food products, unless Congress stepped in.

Last week, both chambers showed they are not interested in waiting around for the FDA to go through the traditional rulemaking process and pressured the agency to proceed with the federal legalization of these products.

House of Representatives

Last Thursday, a collation of twenty-six House members sent a letter to the FDA, urging the agency to develop a path for the lawful marketing of Hemp-CBD products.

The letter provides that while lawmakers appreciate the FDA’s “proactive approach” towards pursuing a legal pathway for the production and sale of Hemp-CBD products, the agency’s current regulatory posture on the matter has created significant regulatory and legal uncertainty for stakeholders.

Specifically, the signatories explained that:

Given the widespread availability of unregulated CBD products, growing consumer demand, and the expected surge in hemp farming in the near future, we believe that FDA must quickly act to provide legal clarity and to establish a regulatory framework that supports this exciting new opportunity.”

Moreover, the lawmakers are hoping that regulatory certainty will provide stakeholders access to banking services and open up new economic opportunities for the industry while at the same time protect consumers.

Lastly, the House members pressed the FDA to consider issuing an interim final rule to establish clear regulatory framework for Hemp-CBD as a dietary supplement and food additive and asked the agency to clarify that while it is developing its rules it is limiting its enforcement discretion towards CBD companies that are making egregious medical claims about their products.

Senate

On the same day the coalition’s letter went out to the agency, Senate Majority Leader Mitch McConnell convinced the Senate Appropriations Committee to incorporate provisions into an agriculture spending bill that directs the FDA to issue enforcement guidelines for Hemp-CBD products.

The spending reports mandates the FDA to clear a path for the lawful marketing of these products within 120 days. This “policy of enforcement discretion” towards CBD products is believed to clarify rules so banks will provide banking services to CBD companies.

According to the language of the provisions, the FDA would be required to submit a report to the Senate Appropriations Committee within 90 days, detailing its “progress toward obtaining and analyzing data to help determine a policy of enforcement discretion, and the process in which CBD meeting the definition of hemp will be evaluated for use in products.”

Once approved, these provisional guidelines would remain in effect until the agency finalizes the regulatory process to enable Hemp-CBD manufacturers to share safety data through existing FDA notification procedures to be fully compliant with federal law and policy.

Overall, both of these effort by U.S. lawmakers show promise in soon forging a path for the lawful sale and marketing of Hemp-CBD products. In pressuring the FDA, both houses acknowledge that the limitations on the marketability of Hemp-CBD has been an ongoing source of frustration that must come to an end to enable the crop and its derived products to meet their economic potential.



source https://hempgenixs.com/2019/09/26/fda-to-clear-a-path-within-four-months-to-lawfully-market-hemp-derived-cbd-products/?utm_source=rss&utm_medium=rss&utm_campaign=fda-to-clear-a-path-within-four-months-to-lawfully-market-hemp-derived-cbd-products

Best CBD Oils For 2019: The Ultimate Test [Pain Relief, Stress, And Anxiety]

You asked for it, so here it is! The results of our ultimate test to find the best CBD oil …

Best CBD Oils For 2019: The Ultimate Test [Pain Relief, Stress, And Anxiety] Read More »

The post Best CBD Oils For 2019: The Ultimate Test [Pain Relief, Stress, And Anxiety] appeared first on CBD School.



source https://hempgenixs.com/2019/09/26/best-cbd-oils-for-2019-the-ultimate-test-pain-relief-stress-and-anxiety/?utm_source=rss&utm_medium=rss&utm_campaign=best-cbd-oils-for-2019-the-ultimate-test-pain-relief-stress-and-anxiety

Vitagenne: A Natural Approach to Balanced Wellbeing (2019 Review + Coupon!)

Vitagenne is a new CBD company born by a group of individuals committed to helping others.  After seeing the “enormous …

Vitagenne: A Natural Approach to Balanced Wellbeing (2019 Review + Coupon!) Read More »

The post Vitagenne: A Natural Approach to Balanced Wellbeing (2019 Review + Coupon!) appeared first on CBD School.



source https://hempgenixs.com/2019/09/26/vitagenne-a-natural-approach-to-balanced-wellbeing-2019-review-coupon/?utm_source=rss&utm_medium=rss&utm_campaign=vitagenne-a-natural-approach-to-balanced-wellbeing-2019-review-coupon

Wednesday, September 25, 2019

Hemp-banking protections pass US House as part of landmark cannabis bill

House lawmakers passed a historic cannabis banking bill Wednesday that also provides a safe harbor for financial institutions serving hemp and hemp-derived CBD businesses. Proponents believed that such provisions were necessary despite the fact that hemp became legal nationwide with the enactment of the 2018 Farm Bill. The hemp amendments in the SAFE Banking Act, […]

Hemp-banking protections pass US House as part of landmark cannabis bill is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/25/hemp-banking-protections-pass-us-house-as-part-of-landmark-cannabis-bill/?utm_source=rss&utm_medium=rss&utm_campaign=hemp-banking-protections-pass-us-house-as-part-of-landmark-cannabis-bill

‘It is not an overnight process’: Q&A with David Gordon of Colombian hemp producer PharmaCielo

(Editor’s note: David Gordon will appear at the MJBizDaily Latin American Cannabis Symposium, Sept. 30-Oct. 1, in Bogota, Colombia.) Cannabis companies are investing heavily in Latin American markets, where low-THC varieties known as hemp in the U.S. play a large role in nascent medical marijuana regulations. The companies that entered Colombia in recent years are seeing […]

‘It is not an overnight process’: Q&A with David Gordon of Colombian hemp producer PharmaCielo is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/25/it-is-not-an-overnight-process-qa-with-david-gordon-of-colombian-hemp-producer-pharmacielo/?utm_source=rss&utm_medium=rss&utm_campaign=it-is-not-an-overnight-process-qa-with-david-gordon-of-colombian-hemp-producer-pharmacielo

UK farmers group endorses hemp products to reduce global warming

Hemp-derived construction components could help reduce greenhouse-gas emissions and should be promoted by the government, according to a new report from an English farmers association. The National Farming Union, a group of about 50,000 farmers in England and Wales, touted hemp construction in a plan detailing ways to get England’s and Wales’ farming industries to […]

UK farmers group endorses hemp products to reduce global warming is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/25/uk-farmers-group-endorses-hemp-products-to-reduce-global-warming/?utm_source=rss&utm_medium=rss&utm_campaign=uk-farmers-group-endorses-hemp-products-to-reduce-global-warming

Terrible, No Good California Cannabis Distribution Contracts

california distribution wholesale

Since January 2018, distributors have played an interesting role in California cannabis. From a regulation perspective, dealing with a distributor is not optional. However, from the business decision vantage point, they’re not all that necessary. Still, some manufacturing and cultivation licensees opt to utilize distributors for sales and retail relationships with the distributor attempting to act like a brand house (more akin to the liquor model). Whether you have a short or long term supply and distribution agreement with a distribution licensees, your basic key terms have to be covered in order to avoid disaster on production and sales (see here for more on that). Lately though in California, I’m seeing more and more terribly written, one-sided distribution agreements that leave me scratching my head when it comes to manufacturers and distributors actually signing on. In turn, this post is dedicated to identifying red flags in distribution agreements in California.

But first, a little history.

As of summer 2017, because of a technical fix to the (now repealed) Medical Cannabis Regulation and Safety Act and Prop. 64, distributors do not have to take title to cannabis products. This of course stripped distributors of what would have been a massive amount of power between cultivators, manufacturers and retailers. And this move by California distinctly pivots the cannabis regulatory model away from the liquor distribution model. Still, all licensees have to use distributors for product transport, mandatory quality assurance testing, quality assurance review (i.e., reviewing packaging and labeling of finished products), and for the collection and remittance of cultivation and excise taxes to the California Department of Tax and Fee Administration.

Whether cultivators and manufacturers utilize distributors to gain greater market share through a distributor’s retail network is completely optional. Some distributors are holding themselves out as having long term sales relationships with retailers that enable the distributor to develop increased brand power across products that an individual manufacturer or retailer wouldn’t otherwise have. Whether that’s actually true or not remains to be seen, but it hasn’t stopped certain distributors from locking manufacturers and cultivators (collectively, “wholesalers”) into truly bad supply and distribution agreements.

If you’re contemplating entering into a more traditional distribution relationship, here’s what should get your Spidey senses tingling:

1.     Supply and Timing. A true distribution agreement is really defined by the amount of supply wholesalers make that the distributor is buying (to sell to retail) and the timing around that production and those sales. Typically, a distributor is going to buy up all or a minimum set amount of wholesaler product on a set schedule or, if the parties so agree, according to specific notice terms that give the wholesaler enough to time to sufficiently perform. The worst distribution agreements in cannabis either don’t clearly identify the amount of product the distributor is supposed to buy, have no minimum purchase standard, or they do identify the amount of product to be bought but give way too short of a notice period to the wholesaler to adequately perform. A good distributor will know the industry and will provide sufficient lead times on certain kinds of production that don’t automatically set up the wholesaler for breach.

2.     Exclusivity. Bad distribution agreements will obfuscate whether the relationship is exclusive or non-exclusive and especially in regard to certain or various product lines. This is a huge mistake really for both sides. And especially if a distributor is obligated to buy up “all of the product produced by a wholesaler.” One great example is if the wholesaler creates a new product line that isn’t mentioned specifically in the distribution agreement. Without being super specific on exclusivity, disputes are bound to occur.

3.     Relationship with Retail. The relationship with retailers is probably the most valuable asset coming out of the distribution agreement. Routinely, distributors will bar wholesalers from making contacting with or selling direct to retailers that are sourced through the distribution agreement. It’s incredibly important then in the agreement (especially in California where distributors don’t have to buy products from wholesalers if wholesalers want to be on retail shelves) to define what retail relationships are included as “off limits” in the contract. For example, if a wholesaler already sold direct to a given retailer in the past and the wholesaler is also within the distributor’s network, ask this question: Is that direct sale relationship locked into the new distribution agreement or not?

4.     Sales, Marketing, Advertising, and Sales Data and Information Rights.  Wholesalers can still afford to be picky with distributors in California. As a result, as a wholesaler, if you have specific conditions around the sales of your product (e.g. price, placement, prominence, store selection), you need to negotiate these with the distributor and not necessarily let the distributor take the helm. In addition, wholesalers should not be hesitant to put the onus on distributors to participate in the marketing and advertising of their products (especially in an exclusive relationship) or to at least force the distributor to assist the wholesaler with its marketing and advertising efforts. The alternative is jockeying for attention amongst all the other wholesalers selling to the distributor and leaving any product promotion or pushing solely up to the distributor at its discretion. In addition, I’ve now seen multiple distributors take away or winnow down the audit and information rights of wholesalers relative to sales performance on wholesaler product. This is a pretty big red flag for wholesalers as that data will tell you how your products are performing in the marketplace compared to your competition and also how hard your distributor is working to support your interests.

5.     Pricing. The parties cannot leave product pricing to chance and expect to have a harmonious or successful relationship. The parties have to obviously negotiate the price (typically per product type) the distributor will pay for the products, and that agreement should be memorialized in the distribution contract (usually in a distributor pricing schedule that’s discounted to account for distributor margins). Distributor pricing strategy is hugely important because too high can drive away the distributor and too low means little to no potential for raising prices in the future. Do yourself a favor though and do not let the distributor completely dictate distributor pricing in the distribution agreement–the parties should actually analyze and be transparent about what makes sense for both keeping retailers happy and maintaining their own bottom lines, which requires a significant amount of look back at past market performance and really knowing the products and market trends.

6.     Payment Terms.  Getting paid from licensee to licensee in California can be a massive challenge because it’s expensive to run a licensed cannabis business and margins are typically not great at any volume. A solid distribution agreement will have a very clear payment schedule (and even protocol for disputes specifically related to getting paid). And there’s a big difference between getting paid when the distributor picks up the product versus getting paid when the product actually sells at the retail level. What’s worse is that some distributors may extend credit to retailers thereby delaying the ultimate pay date for the wholesaler, and if that’s the case the wholesaler should expect to wait a good long time to get paid out. In turn, wholesalers need to really drill down on payment terms in distribution agreements and also research how and when the distributor is usually getting paid by retailers within its retail network.

7.     Territory. Seemingly innocuous at first glance, how the parties define the distribution territory is very important. This is more of a business decision, but wholesalers really need to do diligence on any distributor to see how strong they are throughout California. You otherwise could end up locked down with a distributor that while having immense power and influence in Los Angeles county is a relative unknown with no retail prospects in San Diego county.

8.     Termination and Effect. This, to me, is one of the biggest areas of screw-up in these agreements. Way too often, the distributor has a unilateral, “without cause” right to terminate with however many days notice to the wholesaler. If you’re a wholesaler, this makes you a sitting duck in that a line of sales could vanish with limited notice and you’d be powerless to stop it. Plus, the impact unilateral termination can have on existing orders (if not properly determined) can be devastating to a wholesaler that may have changed its entire business and labor force to accommodate the distribution relationship. And return of product in California is incredibly strict–one you buy cannabis, only infused products can come back down the chain for a return (of a substantially similar or identical product (not for cash)), and only if those products are “defective.” Lastly, when the relationship is over, the question will stand as to whether the wholesaler can still pursue relationship with those retail entities, and if there’s a non-circumvent that’s instituted by the distributor for a matter of years, the wholesaler is SOL. This all goes to highlight how important it is for a wholesaler to take a really detailed look at any termination provisions.

9.     Product Reps and Warranties. Usually, a distributor isn’t going to have robust product representation and warranties. However, in California, where a distributor can store products, has to have them tested, and can package, label, re-package, and re-label flower products, there’s a lot of product handling and interaction going on at a distribution facility. In turn, wholesalers should seek to get at least some reps and warranties around product fitness when in the hands of the distributor (depending on what the distributor will actually do with the product), and indemnification for the same. And of course, any good California cannabis distribution agreement is going to contain succinct protocol for any recall (i.e., who gets to make that call and who’s responsible for the logistics and resulting costs of a recall).

10.     Distributor Bill of Business Health. This goes without saying, but it would surprise you how often wholesalers do zero diligence into the operational history and successes of a distributor. At the outset of the relationship, questions to ask are: does the distributor have a history of honoring its contractual obligations? Does it have a history of damaging material breaches? Does it have a history of litigation? Does it really have that expansive retail network it claims to have? Is it operating in compliance with the law (or, instead, is it allowing an unaccountable, unlicensed third party to do its contractual bidding)? If the distributor can’t or won’t answer these questions, you’re in red flag territory.

Distributors could end up being as important to cannabis as they are in alcohol, despite their lack of power under current regulations. A lot of that hinges though on the actual value add they can provide through their distribution relationships and agreements. It’s a rough market out there right now because California is still emerging, and wholesalers need to be very careful when evaluating whether to ink a distribution agreement (or not).



source https://hempgenixs.com/2019/09/25/terrible-no-good-california-cannabis-distribution-contracts/?utm_source=rss&utm_medium=rss&utm_campaign=terrible-no-good-california-cannabis-distribution-contracts

HaraFlow CEO Brody Shemansky Discusses CBD for Athletes

CBD is a growing industry in 2019, due to provisions in the 2018 Farm Bill that legalize commercial hemp farming.  …

HaraFlow CEO Brody Shemansky Discusses CBD for Athletes Read More »

The post HaraFlow CEO Brody Shemansky Discusses CBD for Athletes appeared first on CBD School.



source https://hempgenixs.com/2019/09/25/haraflow-ceo-brody-shemansky-discusses-cbd-for-athletes/?utm_source=rss&utm_medium=rss&utm_campaign=haraflow-ceo-brody-shemansky-discusses-cbd-for-athletes

Tuesday, September 24, 2019

Canadian cannabis company planning to grow 17,000 acres of hemp in China

A Toronto marijuana producer is making plans to grow hemp in China to make CBD and other hemp products. Pure Global Cannabis announced Tuesday it signed an agreement to grow roughly 17,000 acres of hemp in the Yunnan province. Pure Global Cannabis says it will operate its China hemp operation with another company, KMT-Hansa Corp. […]

Canadian cannabis company planning to grow 17,000 acres of hemp in China is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/24/canadian-cannabis-company-planning-to-grow-17000-acres-of-hemp-in-china/?utm_source=rss&utm_medium=rss&utm_campaign=canadian-cannabis-company-planning-to-grow-17000-acres-of-hemp-in-china

CBD drug Epidiolex approved for use in Europe, GW Pharmaceuticals says

The only federally approved CBD product in the U.S. has been OK’d by European authorities for use there. The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In June 2018, the U.S. Food and Drug Administration approved Epidiolex for the treatment of seizures associated with two rare kinds […]

CBD drug Epidiolex approved for use in Europe, GW Pharmaceuticals says is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/24/cbd-drug-epidiolex-approved-for-use-in-europe-gw-pharmaceuticals-says/?utm_source=rss&utm_medium=rss&utm_campaign=cbd-drug-epidiolex-approved-for-use-in-europe-gw-pharmaceuticals-says

Arthritis Foundation issues CBD guidance, a first among major patient advocacy groups

The Arthritis Foundation became the first major patient advocacy group to issue CBD recommendations, telling some 50 million arthritis patients Tuesday what to look for when choosing CBD. The group did not recommend using CBD to treat arthritis symptoms, though it noted that people with arthritis show “significant use of and interest in CBD” for […]

Arthritis Foundation issues CBD guidance, a first among major patient advocacy groups is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/09/24/arthritis-foundation-issues-cbd-guidance-a-first-among-major-patient-advocacy-groups/?utm_source=rss&utm_medium=rss&utm_campaign=arthritis-foundation-issues-cbd-guidance-a-first-among-major-patient-advocacy-groups

Cannabis Trademark Litigation: Web Platform Liability (Mr. T v. Leafly)

mr t leafly cannabis website trademark

On August 22, 2019, actor Mr. T, best known as a star of the TV series “The A-Team,” sued Leafly Holdings Inc. for trademark infringement. The lawsuit was filed after Mr. T’s attorneys sent multiple cease and desist letters to Leafly, which were allegedly ignored.

The lawsuit stems from Leafly’s listing of a strain called “Mr. Tusk,” which is sold by third-party cannabis retailers. Leafly utilizes a three-letter periodic table-style tile design for all of its listings, and the particular tile used for the Mr. Tusk strain is “Mrt.”

In his cease and desist letters, Mr. T alleges that Leafly’s unauthorized use of Mr. T’s name “is likely to cause damage to the commercial value of his right of publicity. It also creates a false or misleading inference of endorsement, approval, or sponsorship of [Leafly’s] products by Mr. T and is a violation of his valuable trademark rights.”

In order to prevail on a trademark infringement claim, a plaintiff must show a “likelihood of confusion” on the part of consumers meaning, in this case, that consumers would assume that Mr. T endorses or is in some way affiliated with the Leafly listing. A court will consider eight factors in evaluating a likelihood of confusion argument (AMF Inc. v. Sleekcraft Boats):

  • Strength of the mark;
  • Proximity of the goods;
  • Similarity of the marks;
  • Evidence of actual confusion;
  • Marketing channels used;
  • Type of goods and degree of care likely to be exercised by the purchaser;
  • Defendant’s intent in selecting the mark; and
  • Likelihood of expansion of the product lines.

Here, of course, both sides contend that analysis of the factors weighs in their favor.

However, and this is what makes this trademark infringement claim particularly interesting, Leafly is not actually using the “Mrt” tile to sell its own products. Leafly does not sell or distribute any cannabis products, and doesn’t come up with the names for the products it lists on its site. Can Leafly then be held liable for infringement of Mr. T’s trademarks?

There has been a good amount of debate in recent years regarding the extent to which e-commerce platforms can be held liable for trademark infringement involving third-party content. The Digital Millennium Copyright Act (DMCA), which applies to copyrights, provides that hosting providers are not liable for third-party copyright infringing content unless they (1) have knowledge of the infringing content; and (2) do not take down the infringing content expeditiously. Although the DMCA does not apply to trademark infringement, courts have applied similar principles based on contributory and vicarious liability.

A case that illustrates where U.S. courts have drawn the line on this issue is that of Tiffany v. eBay, where Tiffany sued eBay for trademark infringement after finding that thousands of pieces of counterfeit “Tiffany” jewelry had been sold on the platform. The court ultimately dismissed Tiffany’s claims, holding that eBay was neither directly nor indirectly liable for third party sales of the counterfeit goods on its platform because Tiffany could not show that eBay had specific knowledge of specific infringing items. eBay therefor had no affirmative duty to remedy the situation.

But here, Mr. T’s attorneys sent multiple letters to Leafly asking that they remove the allegedly infringing content, which Leafly declined to do. Additionally, in his complaint, Mr. T has alleged that “[t]here is a direct connection between the use of ‘Mr. T’ and the commercial purpose of advertising a cannabis strain as it is listed on the Leafly website,” and also that Leafly and Does 1 through 9 (the unidentified cannabis sellers) were “actual, implied or ostensible agents, servants, employees, partners, joint venturers, alter egos and/or co-conspirators of one another, and were at all relevant times … acting on behalf of one another …” It is clear that Mr. T’s counsel does not view Leafly as a mere passive, third-party platform that can’t be liable for the trademark infringement of its advertising customers.

We’ll be curious to see how this one plays out. Mr. T is primarily seeking, through injunctive relief, for Leafly to change the “Mrt” tile. He is not seeking damages. Regardless of the court’s decision, web platforms that provide listing and advertising services for cannabis companies should take note – trademark litigation is expensive, and the conduct of your customers could land you in hot water. Be sure that the agreements you have in place with third parties listing on your site address these types of scenarios, and have a protocol in place for addressing complaints from third-parties of copyright and trademark infringement.



source https://hempgenixs.com/2019/09/24/cannabis-trademark-litigation-web-platform-liability-mr-t-v-leafly/?utm_source=rss&utm_medium=rss&utm_campaign=cannabis-trademark-litigation-web-platform-liability-mr-t-v-leafly